Thus, triptolide exhibits multifaceted anti-cancer effects by modulating the tumor immune microenvironment, depleting immunosuppressive macrophages, promoting T cell activity, and inhibiting immune checkpoint proteins like PD-L1. Here, CD274 is linked to neoplasm.